{"id":14961,"date":"2026-08-07T12:01:03","date_gmt":"2026-08-07T12:01:03","guid":{"rendered":"https:\/\/news.theck1.no\/?p=14961"},"modified":"2026-08-07T12:01:03","modified_gmt":"2026-08-07T12:01:03","slug":"modernas-mrna-flu-shot-earns-fda-approval-after-rollercoaster-review","status":"publish","type":"post","link":"https:\/\/news.theck1.no\/?p=14961","title":{"rendered":"Moderna&#8217;s mRNA flu shot earns FDA approval after rollercoaster review"},"content":{"rendered":"<div style=\"margin-bottom:1em; color:#666; font-size:0.9em;\">\n<strong><br \/>\n                    Beth Mole<br \/>\n                <\/strong><br \/>\n &bull;<br \/>\nAugust 6, 2026\n<\/div>\n<hr\/>\n<p>Despite significant drama from Trump officials this year, the Food and Drug Administration has for the first time approved a flu vaccine that uses mRNA technology.<\/p>\n<p>On Thursday, vaccine maker <a href=\"https:\/\/feeds.issuerdirect.com\/news-release.html?newsid=4801915282452025&amp;symbol=MRNA\">Moderna announced<\/a> that its flu shot, mRNA-1010, aka mFLUSIVA, had earned approval for use in all adults ages 50 and up. The approval announcement follows a <a href=\"https:\/\/arstechnica.com\/health\/2026\/06\/fda-advisors-unanimously-vote-to-approve-modernas-mrna-after-agency-drama\/\">unanimous vote by FDA advisors in June to approve the vaccine<\/a>. That vote was based on its superior efficacy to existing seasonal flu shots and a good safety record demonstrated in trials that included nearly 44,000 people. After that vote, the FDA set a goal of August 5 for a decision on the vaccine&#8217;s fate.<\/p>\n<p>While the unanimous support from FDA advisors boded well for Moderna&#8217;s shot, the overall path to approval was treacherous and uncertain, even until the end. For one thing, current Health Secretary Robert F. Kennedy Jr. is a well-established anti-vaccine advocate who has worked diligently in his time in office to thwart vaccinations. One of his first acts as health secretary was <a href=\"https:\/\/www.nytimes.com\/2026\/06\/25\/us\/politics\/kennedy-cdc-emails.html\">canceling a federal campaign to encourage people to get flu shots<\/a> in the midst of a bad flu season\u2014despite the fact that the Centers for Disease Control and Prevention had already paid for the campaign and the flu season was killing relatively high numbers of children.<\/p>\n<p><a href=\"https:\/\/arstechnica.com\/health\/2026\/08\/modernas-mrna-flu-shot-earns-fda-approval-after-rollercoaster-review\/\">Read full article<\/a><\/p>\n<p><a href=\"https:\/\/arstechnica.com\/health\/2026\/08\/modernas-mrna-flu-shot-earns-fda-approval-after-rollercoaster-review\/#comments\">Comments<\/a><\/p>\n<p style=\"margin-top:1.5em;\"><a href=\"https:\/\/arstechnica.com\/health\/2026\/08\/modernas-mrna-flu-shot-earns-fda-approval-after-rollercoaster-review\/\" target=\"_blank\" rel=\"noopener\">Read the full article &rarr;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Beth Mole &bull; August 6, 2026 Despite significant drama from Trump officials this year, the Food and Drug Administration has for the first time approved a flu vaccine that uses mRNA technology. On Thursday, vaccine maker Moderna announced that its flu shot, mRNA-1010, aka mFLUSIVA, had earned approval for use in all adults ages 50<\/p>\n<p class=\"more-link\"><a href=\"https:\/\/news.theck1.no\/?p=14961\" class=\"themebutton2\">READ MORE<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-14961","post","type-post","status-publish","format-standard","hentry","category-artificial-intelligence"],"_links":{"self":[{"href":"https:\/\/news.theck1.no\/index.php?rest_route=\/wp\/v2\/posts\/14961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/news.theck1.no\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.theck1.no\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.theck1.no\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news.theck1.no\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=14961"}],"version-history":[{"count":0,"href":"https:\/\/news.theck1.no\/index.php?rest_route=\/wp\/v2\/posts\/14961\/revisions"}],"wp:attachment":[{"href":"https:\/\/news.theck1.no\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=14961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.theck1.no\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=14961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.theck1.no\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=14961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}